Biozidprodukteg Gebührentarifv 2014 - Bp Gebtv 2014

Original Language Title: BiozidprodukteG-GebührentarifV 2014 – BP-GebTV 2014

Read the untranslated law here: http://www.ris.bka.gv.at/Dokumente/BgblAuth/BGBLA_2014_II_291/BGBLA_2014_II_291.html

291. Decree of the Federal Minister for agriculture and forestry, environment and water management relating to fees in accordance with the Regulation (EU) No. 528/2012 on the making available on the market and use of biocidal products (BiozidprodukteG GebührentarifV 2014 - BP GebTV 2014)

On the basis of §§ 4, 5, 7, 11 and 25 of the Federal Act for the implementation of the biocidal products Act, Federal Law Gazette I no. 105/2013, (in the following: BiozidprodukteG), is prescribed:

1. (1) the fees for



1. a request for approval or extension of approval of an active substance in accordance with articles 7 to 16 of the Regulation (EU) No. 528/2012 on the making available on the market and use of biocidal products, OJ No. L 167 of the 27 06 2012 S. 1 (hereafter: biocidal product regulation) and an application for inclusion of an active substance in the list of in annex I in accordance with article 28 of the biocidal product regulation, 2. a message of a biocidal product within an approved biocidal product family in accordance with article 17 para. 6 of the biocidal product regulation, 3. a request for authorisation of a biocidal product or a biocidal product family in accordance with article 17 and 29 of the biocidal product regulation , 4. a request for authorisation of a biocidal product or a biocidal product family within the framework of the simplified approval procedure in accordance with articles 25 and 26 of the biocidal product regulation, 5. a notification of the deployment on the market of a biocidal product authorised under the simplified procedure in accordance with article 27 of the biocidal product regulation, 6. a request for authorisation of a biocidal product or a biocidal product family in the way of mutual recognition pursuant to article 33 or 34 of the biocidal product regulation , 7 an application for authorisation of a biocidal product or a family of biocidal products within the scope of Union approvals in accordance with articles 41 to 44 of the biocidal product regulation, 8 a request for authorisation of a biocidal product or a biocidal product family for parallel trade in accordance with article 53 of the biocidal product regulation, 9 an application for authorisation of a biocidal product or a biocidal product family in danger in delay in accordance with article 55 paragraph 1 of the biocidal product regulation, 10 one application for provisional registration of a biocidal product or a family of biocidal products in accordance with article 55 para 2 of the biocidal product regulation , 11 a message of any experiment or test for research and development purposes pursuant to article 56 of the biocidal product regulation, 12 an application for amendment of approvals or approvals to Z 3, 4, 6, 7, 8, 9 and 10, 13 an application for renewal of approvals or approvals to Z 3, 4, 5, 6, 7, 8, 9 and 10 and 14 a authorised biocidal product or a biocidal product family , except a biocidal product approved after no. 7 in the framework of a Union approval or a biocidal product family per year are set in the system.

(2) the total fee for an application, a message or a notification referred to in paragraph 1 includes, where appropriate, a validation fee (VG), which serves the formal completeness of the information and documents in the context of the procedure for the examination, and a review fee (BG) for assessing the particulars and documents concerning the existence of the material requirements for the registration of installing in accordance with the applicable tariff items of plant.

(3) for the application of the applicable tariff items of sections I to IX of the annex, where the relevant fee is set, for the treatment of installing prevail the nature of attaching the biocidal product or the respective biocidal product family, attaching refers to, necessary and unused official activities and the amount of documents to be examined.

(4) the fees in accordance with the annex shall be paid not later than 30 days after notification by the authority. Initially only a validation fee is intended for an application must be made. The assessment fee is payable within 30 days after notification has been validated by the authority. For small and medium-sized enterprises (SMEs) in accordance with article 3 par. 1 lit. æ of the biocidal product regulation can pay the evaluation fee if she exceed the amount of € 50.000, be made in instalments. The period for part payments must exceed a maximum of five years. Proof of compliance with the criteria of an SME is to attach.

(5) the authority may, set in individual cases unless the assessment of an active substance in cases of section I footnote 1, 2 or 3 of the plant with significantly less administrative effort is connected, a lower evaluation fee.

(6) any subsequent withdrawal, refusal or rejection of the application has no effect on the level of fees normally. The authority may set a lower evaluation fee in these cases, if the applicant does not timely submitted required data, the proposed authorization or approval may not be granted and decreases the regulatory effort this.

(7) adult authority in danger in delay in accordance with article 55 § 1 of the biocidal product regulation by the assessment of an active substance within the framework of an application for authorisation of a biocidal product in the cases of paragraph 1 Z has 9 cash expenses, the applicant in accordance with section 76 of the General administrative procedures Act 1991 - AVG, Federal Law Gazette No. 51/1991, as last amended by Federal Law Gazette I no. 161/2013 , to pay.

(8) adult cash outlay, no tariff items are provided for the in the system, the authority the processing of a request referred to in paragraph 1 has the applicant in accordance with section 76 to pay AVG. The para 2 to 7 are to apply by analogy.

(9) the annual fees (JG) for approved biocidal products or biocidal product families, referred to in paragraph 1 shall be payable until 31 March of the following year Z 14. You are first due after the end of the calendar year of their admission.

§ Adult authority by the transmission or through the examination of samples of a biocidal product in the application procedure in accordance with article 53 lit 2 para 4. h biocidal product regulation cash outlay, so has to pay AVG for these out-of-pocket expenses the applicant in accordance with section 76.

§ 3. If no further fees, they are of the authority decision to prescribe.

4. (1) this regulation with the day following the by-laws enter into force.

(2) the biocidal products act GebührentarifV I, Federal Law Gazette II No. 251/2002 and the biocidal products act GebührentarifV II, Federal Law Gazette II No. 331/2003 amended regulation Federal Law Gazette II No. 75/2012, become at the end of the day of the by-laws override.

(3) pending at the time of entry into force of this regulation procedure in accordance with the transitional provision of article 91 of the biocidal product regulation the assessment to be carried out has exclusively according to Directive 98/8/EC, the calling rates in accordance with the legislation referred to in paragraph 2 shall apply.

(4) as referred to in paragraph 3, pending at the time of entry into force of this regulation, the rates of fees in accordance with the legislation referred to in paragraph 2 for others only apply when at this time with the review already has been started.

(5) biocidal products or biocidal product families that are approved at the time of entry into force of this regulation, apply with respect to the annual fees to be paid as approved for the first time in 2014. Biocidal products that are approved within a defined framework formulation, apply with respect to the annual fees to be paid as a biocidal product family.

Raj

Plant

Section I

1. fees for applications for approval and renewal of the approval of an active substance in accordance with article 7 to 16 of the biocidal product regulation



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







VG





1.1.1





Assessment of an application for approval of an active substance (chemical substance) in accordance with article 8 of the biocidal product regulation, if necessary plus additional fee according to tariff item 1.1.3, 1.4.5, 8.1.1, 8.1.2, 8.1.3, 8.1.4, 8.1.5, 8.1.6





32 000-







BG





1.1.2





218 000,-1), 2).







BG





1.1.3





Additional charge for the evaluation of any other product type approval of an active substance; In addition to tariff post 1.1.2





88 000







 





 





 





 







VG





1.1.4





Assessment of an application for approval of an active substance (micro-organism) in accordance with article 8 of the biocidal product regulation, if necessary plus additional fee according to tariff item 1.1.6, 1.4.5, 8.1.1, 8.1.2, 8.1.3, 8.1.4, 8.1.5, 8.1.6





20 000-







BG





1.1.5





140 000,-3)







BG





1.1.6





Additional charge for the evaluation of any other product type approval of an active substance; In addition to tariff post 1.1.5





56 000







 





 





 





 







VG





1.2.1






Assessment of the application for renewal of the authorisation of a substance (chemical substance) in accordance with article 14 of the biocidal product regulation, which has not yet been rated by Austria as reference Member State and of a comprehensive review might be required, plus additional fee according to tariff item 1.2.3, 1.4.5





26 000







BG





1.2.2





182 000,-1), 2).







BG





1.2.3





Additional charge for the evaluation of any other product in the renewal of the approval of an active substance; In addition to tariff post 1.2.2





70 000







 





 





 





 







VG





1.2.4





Assessment of the application for renewal of the authorisation of a substance (chemical substance) in accordance with article 14 of the biocidal product regulation, which has been already reviewed by Austria as a reference Member State, and where a comprehensive assessment is required, if applicable plus additional fee according to tariff item 1.2.6, 1.4.5





24 000







BG





1.2.5





164 000,-1), 2).







BG





1.2.6





Additional charge for the evaluation of any other product in the renewal of the approval of an active substance; In addition to tariff post 1.2.5





65 000







 





 





 





 







VG





1.2.7





Assessment of the application for renewal of the authorisation of a substance (micro-organism) in accordance with article 14 of the biocidal product regulation, which has not yet been rated by Austria as reference Member State and of a comprehensive review might be required, plus additional fee according to tariff item 1.2.9, 1.4.5





16 000-







BG





1.2.8





116 000,-3)







BG





1.2.9





Additional charge for the evaluation of any other product in the renewal of the approval of an active substance; In addition to tariff post 1.2.8





46 000







 





 





 





 







VG





1.2.10





Assessment of the application for renewal of the authorisation of a substance (micro-organism) in accordance with article 14 of the biocidal product regulation, which has been already reviewed by Austria as a reference Member State, and where a comprehensive assessment is required, if applicable plus additional fee according to tariff item 1.2.12, 1.4.5





15 000-







BG





1.2.11





100 000,-3)







BG





1.2.12





Additional charge for the evaluation of any other product in the renewal of the approval of an active substance; In addition to tariff post 1.2.11





40 000-







 





 





 





 







VG





1.3.1





Assessment of the application for renewal of the authorisation of a substance (chemical substance) in accordance with article 14 of the biocidal product regulation, which has not yet been rated by Austria as reference Member State and where no comprehensive review might be required, plus additional fee according to tariff post 1.3.3





15 600







BG





1.3.2





109 400-







BG





1.3.3





Additional charge for the evaluation of any other product in the renewal of the approval of an active substance; In addition to tariff post 1.3.2





25 000-







 





 





 





 







VG





1.3.4





Assessment of the application for renewal of the authorisation of a substance (chemical substance) in accordance with article 14 of the biocidal product regulation, which already rated by Austria as a reference Member State and where no comprehensive assessment might be required, plus additional fee according to tariff post 1.3.6





12 000-







BG





1.3.5





82 000-







BG





1.3.6





Additional charge for the evaluation of any other product in the renewal of the approval of an active substance; In addition to tariff post 1.3.5





19 000-







 





 





 





 







VG





1.3.7





Assessment of the application for renewal of the authorisation of a substance (micro-organism) in accordance with article 14 of the biocidal product regulation, which has not yet been rated by Austria as reference Member State and where no comprehensive evaluation might be required, plus additional fee according to tariff post 1.3.9





9 300







BG





1.3.8





65 700-







BG





1.3.9





Additional charge for the evaluation of any other product in the renewal of the approval of an active substance; In addition to tariff post 1.3.8





15 000-







 





 





 





 







VG





1.3.10





Assessment of the application for renewal of the authorisation of a substance (micro-organism) in accordance with article 14 of the biocidal product regulation, which already rated by Austria as a reference Member State and where no comprehensive assessment might be required, plus additional fee according to tariff post 1.3.12





7 000-







BG





1.3.11





49 000







BG





1.3.12





Additional charge for the evaluation of any other product in the renewal of the approval of an active substance; In addition to tariff post 1.3.11





11 000





1) 1.Wenn a) the submission of inspection certificates in accordance with annex II title 1 point 8 or 9 of the biocidal product regulation of scientific reasons is not needed in total or on no more than two inspection reports from annex II title 1 point 8.1 to 8.4 and 8.7 or point 8.5 and 8.6. or from annex II title 1 point 9.1.2 or 9.1.4 the biocidal product regulation can be restricted or when carrying out the corresponding tests is not technically possible and the necessary professional final Justification for not template is finally accepted by the authority, or b) for these test certificates of the applicant a valid and qualifying existing audit evidence to the reference to valid and transferable, the authority letter of access of the owner in accordance with article 3 par. 1 lit. t of the biocidal product regulation is presented, reduced the fees of the tariff post 1.1.2 on 167 euro 900, the collective post 1.2.2 on 140 100,-euro and the collective post 1.2.5 on 126 300,-euro.

2. If a) is not needed in total submission of inspection certificates in accordance with annex II title 1 point 8 and 9 of the biocidal product regulation for scientific reasons or on no more than two inspection reports from annex II title 1 point 8.1 to 8.4 and 8.7 or point 8.5 and 8.6. and annex II title 1 point 9.1.2 or 9.1.4 the biocidal product regulation can be restricted or when carrying out the corresponding tests is not technically possible and the necessary professional final Justification for not template is finally accepted by the authority, or b) for these test certificates of the applicant a valid and qualifying existing audit evidence to the reference to valid and transferable, the authority letter of access of the owner in accordance with article 3 par. 1 lit. t of the biocidal product regulation is presented, reduced the fees of the tariff post 1.1.2 on 117 700 euro, the collective post 1.2.2 on 98 200,-euro and the collective post 1.2.5 on 90 200,-euro.

(2) If 1 scientific reasons at least the submission of inspection certificates in accordance with annex II title 1 point 8.9.3, 8.9.4, 8.11 and 8.10.3 of biocidal product regulation that is not required or when carrying out the corresponding tests is not technically possible and the necessary professional final justification for not submitting the authority is finally accepted, or 2 at least for the scope of the referred to in subpara 1 that the Authority already present inspection certificates of the applicant a valid and to the reference to transferable and valid VAT audit evidence letter of access of the owner in accordance with article 3 par. 1 lit. t of the biocidal product regulation is presented, reduced the fees of the tariff post 1.1.2 on 200 500,-euro, the collective post 1.2.2 on 165 600,-euro or the collective post 1.2.5 on 150 euro 900.

(3) 1.

If for the entire scope of the audit evidence in accordance with annex II title 2 point 7 or for the entire scope of the audit evidence in accordance with annex II, title one 2 points 8 and 9 of the biocidal product regulation by the applicant legally binding and qualifying existing, valid and portable test certificates for the reference to the authority letter of access of the owner in accordance with article 3 par. 1 lit. t of the biocidal product regulation is presented, the fees of the tariff post 1.1.5 120 400,-euro, the tariff post of 1.2.8 on 99 800,-euro and the tariff post reduced 1.2.11 on 86 000,-euro.

2. If for the entire scope of the audit evidence in accordance with annex II title 2 point 7 and for the entire scope of the audit evidence in accordance with annex II, title 2 points 8 and 9 of the biocidal product regulation by the applicant presented a letter of such access, the fees of the tariff post 1.1.5 on 102 200 euro, the tariff post of 1.2.8 on 84 700,-euro and the tariff post reduced 1.2.11 to 73 000 , - Euro.

2. fees for requests for the inclusion of active substances in annex I of the biocidal product regulation in accordance with article 28



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







VG





1.4.1





Assessment of the application for inclusion of an active substance in annex I, category 1 to 5 in accordance with article 28 of the biocidal product regulation, which already published and reviewed, or contains data generated by the concept of analogy





18 000-







BG





1.4.2





56 000







 





 





 





 







VG





1.4.3





Assessment of the application for inclusion of an active substance in annex I, category 6 in accordance with article 28 of the biocidal product regulation





20 000-







BG





1.4.4





140 000-







 





 





 





 







BG





1.4.5





Additional fee for the verification of compliance with the criteria laid down in article 28 paragraph 2 for inclusion of an active substance in annex I, article 9 of the biocidal product regulation has been evaluated already with regard to the approval according to

In addition to tariff item 1.1.2, 1.1.5, 1.2.2, 1.2.5





5 000-





Section II

Fees 17 and 29 and articles 31 and 34 for the assessment of applications within the framework of the national authorisation and renewal of the national authorisation of a biocidal product or a family of biocidal products in accordance with article para. 1 of the biocidal product regulation, if Austria as a reference Member State carries out the evaluation

Of the following fees are each a biocidal product or a biocidal product family to apply for, which should contain an active ingredient and allowed for a kind of product and a user category. If applicable, the additional fee referred to in section VIII shall apply.



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







VG





2.1.1





Assessment of the application for a national authorisation of a biocidal product in accordance with article 29 or article 34 para 1 of the biocidal product regulation, if necessary plus fees pursuant to tariff item 8.2.1, 8.4.1, 8.4.2, 8.6.1, 8.6.2, 8.11.1





5 600







BG





2.1.2





39 400-







 





 





 





 







VG





2.1.3





Assessment of the application for a national authorisation of a biocidal product family in accordance with article 29 or article 34 para 1 of the biocidal product regulation, if necessary plus fees pursuant to tariff item 8.2.2, 8.4.3, 8.4.4, 8.6.3, 8.6.4 8.11.1





11 300-







BG





2.1.4





78 700-







 





 





 





 







VG





2.2.1





Assessment of the application for a national authorisation of a biocidal product article 29 or article 34 para 1 of the biocidal product regulation, which is identical to the reference product, assessed for active substance approval





1.800-







BG





2.2.2





12 450-







 





 





 





 







VG





2.2.3





Assessment of an application for a national authorisation of a biocidal product family in accordance with article 29 or article 34 para 1 of the biocidal product regulation, which is identical to the reference product, which was assessed for active substance approval





3 500-







BG





2.2.4





25 000-







 





 





 





 







VG





2.3.1





Assessment of the application for renewal of a national authorisation of a biocidal product in accordance with article 31 of the biocidal product regulation, of a comprehensive assessment is required, if necessary plus applicable fees under tariff item 8.3.1, 8.5.1, 8.5.2, 8.6.5





4 600-







BG





2.3.2





32 400-







 





 





 





 







VG





2.3.3





Assessment of the application for renewal of a national authorisation of a biocidal product family in accordance with article 31 of the biocidal product regulation, of a comprehensive assessment is required, if necessary plus applicable fees under tariff item 8.3.2, 8.5.3, 8.5.4, 8.6.6





9 200







BG





2.3.4





64 800-







 





 





 





 







VG





2.3.5





Assessment of the application for renewal of a national authorisation of a biocidal product in accordance with article 31 of the biocidal product regulation, where no comprehensive assessment is required, if applicable plus applicable fees under tariff item 8.3.3, 8.5.6





1 500-







BG





2.3.6





10 400-







 





 





 





 







VG





2.3.7





Assessment of the application for renewal of a national authorisation of a biocidal product family in accordance with article 31 of the biocidal product regulation, where no comprehensive assessment is required, if applicable plus applicable fees under tariff item 8.3.4, 8.5.8





3 000-







BG





2.3.8





20 800-







 





 





 





 







BG





2.4.1





Review a message of a biocidal product, that belongs to a biocidal product family para. 6 of the biocidal product regulation in accordance with article 17





1 500-







 





 





 





 







BG





2.4.2





Assessment of the application for authorisation of a same biocidal product in accordance with article 17 para 7 of the biocidal product regulation in conjunction with Regulation (EU) No. 414/2013, if the application only an administrative amendment annex title I includes section 1 or section 2 Regulation (EU) No. 354/2013





1 000-







 





 





 





 







BG





2.4.3





Assessment of the application for authorisation of a same biocidal product in accordance with article 17 para 7 of the biocidal product regulation in conjunction with Regulation (EU) No. 414/2013, unless the request several administrative changes according to annex title I section 1 and section 2 Regulation (EU) No. 354/2013 includes





1 500-







 





 





 





 







BG





2.4.4





Assessment of the application for approval of a same family of biocidal products in accordance with article 17 para 7 of the biocidal product regulation in conjunction with Regulation (EU) No. 414/2013, if the application only an administrative amendment annex title I includes section 1 or section 2 Regulation (EU) No. 354/2013





2 000-







 





 





 





 







BG





2.4.5





Assessment of the application for approval of a same family of biocidal products in accordance with article 17 para 7 of the biocidal product regulation in conjunction with Regulation (EU) No. 414/2013, unless the request several administrative changes, in accordance with annex title I includes section 1 and section 2 Regulation (EU) No. 354/2013





3 000-





Section III


Fees for applications for registration and renewal of the authorisation of a biocidal product or a biocidal product family within the framework of the simplified approval procedure in accordance with article 17 para 6, 25 and 26 and article 27 paragraph 1 of the biocidal product regulation



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





3.1.1





Assessment of the application for authorisation of a biocidal product within the framework of the simplified approval procedure in accordance with articles 25 and 26 of the biocidal product regulation, category 1, 2, 3, 4, 5, or 7 contains an active substance in annex I





10 000-







 





 





 





 







BG





3.1.2





Assessment of the application for authorisation of a biocidal product within the framework of the simplified approval procedure in accordance with articles 25 and 26 of the biocidal product regulation, category 6 contains an active substance in annex I





5 000-







 





 





 





 







BG





3.1.3





Assessment of the application for authorisation of a biocidal product within the framework of the simplified approval procedure in accordance with articles 25 and 26 of the biocidal product regulation, which is identical to the reference product, category 6 was valued for active substance included in annex I





2 000-







 





 





 





 







BG





3.2.1





Assessment of the application for authorisation of a biocidal product family within the framework of the simplified approval procedure in accordance with articles 25 and 26 of the regulation of biocidal product containing an active substance in annex I category 1, 2, 3, 4, 5, or 7





14 300







 





 





 





 







BG





3.2.2





Assessment of the application for authorisation of a biocidal product family within the framework of the simplified approval procedure in accordance with articles 25 and 26 of the biocidal product regulation, category 6 containing an active substance in annex I





5 000







 





 





 





 







BG





3.3.1





Assessment of the application for renewal of an authorisation for a biocidal product within the framework of the simplified approval procedure





3 000-







 





 





 





 







BG





3.3.2





Assessment of the application for renewal of an authorisation for a biocidal product family within the framework of the simplified approval procedure





6 000-







 





 





 





 







BG





3.4.1





Review a message of a biocidal product which is part of para. 6 the biocidal product regulation a biocidal product family in accordance with article 17, which was approved according to the simplified approval procedure





300-







 





 





 





 







BG





3.4.2





Evaluation a briefing about how to deploy on the market of a biocidal product authorised under the simplified approval procedure in another Member State in accordance with article 27 paragraph 1 of the biocidal product regulation, category 1, 2, 3, 4, 5, or 7 containing an active substance in annex I





2 000-







 





 





 





 







BG





3.4.3





Evaluation a briefing about how to deploy on the market of a biocidal product authorised under the simplified approval procedure in another Member State in accordance with article 27 paragraph 1 of the biocidal product regulation, that category 6 contains an active substance in annex I





1 000-







 





 





 





 







BG





3.4.4





Evaluation a briefing about how to deploy on the market of a biocidal product family approved under the simplified approval procedure in another Member State in accordance with article 27 paragraph 1 of the biocidal product regulation, category 1, 2, 3, 4, 5, or 7 containing an active substance in annex I





3 000-







 





 





 





 







BG





3.4.5





Evaluation a briefing about how to deploy on the market of a biocidal product family approved under the simplified approval procedure in another Member State in accordance with article 27 paragraph 1 of the biocidal product regulation, category 6 containing an active substance in annex I





1 500-







 





 





 





 







BG





3.4.6





Evaluation a briefing about how to deploy a biocidal product on the market, was that belongs to a biocidal product family, which has been approved according to the simplified authorisation procedure in another Member State, and which is already registered in another Member State





300-





Section IV

Fees for applications for registration and renewal of the authorisation of a biocidal product or a biocidal product family in the way of mutual recognition in accordance with article 17 para. 6, art. 33 and 34 para 2 of the biocidal product regulation, if Austria is the Member State concerned

Of the following fees are each a biocidal product or a biocidal product family to apply for, which should contain an active ingredient and allowed for a kind of product and a user category. If applicable, the additional fee referred to in section VIII shall apply.



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





4.1.1





Assessment of the application for authorisation of a biocidal product in the way of mutual recognition in accordance with article of 33 and 34 para 2 of the biocidal product regulation, if necessary plus fees pursuant to tariff item 8.7.1, 8.8.1, 8.8.2, 8.10.1, 8.10.2





7 700-







 





 





 





 







BG





4.1.2





Assessment of the application for authorisation of a biocidal product family in the way of mutual recognition in accordance with article of 33 and 34 para 2 of the biocidal product regulation, if necessary plus fees pursuant to tariff item 8.7.2, 8.8.3 8.8.4 8.10.3, 8.10.4





15 400-







 





 





 





 







BG





4.2.1





Assessment of the application for renewal of an authorisation of a biocidal product in the way of mutual recognition in accordance with article of 33 and 34 para 2 of the biocidal product regulation, of a comprehensive assessment is required if applicable plus fees pursuant to tariff item 8.7.3, 8.9.1, 8.9.2





6 200







 





 





 





 







BG





4.2.2





Assessment of the application for renewal of authorisation of a biocidal product family in the way of mutual recognition in accordance with article of 33 and 34 para 2 of the biocidal product regulation, of a comprehensive assessment is required if applicable plus fees pursuant to tariff item 8.7.4, 8.9.3, 8.9.4





12 400-







 





 





 





 







BG





4.2.3





Review an application for renewal of an authorisation of a biocidal product in the way of mutual recognition in accordance with article of 33 and 34 para 2 of the biocidal product regulation, the no comprehensive assessment is required, if necessary plus applicable fees under tariff item 8.7.5, 8.9.5 8.9.6





2 100-







 





 





 





 







BG





4.2.4





Assessment of the application for renewal of authorisation of a biocidal product family in the way of mutual recognition in accordance with article of 33 and 34 para 2 of the biocidal product regulation, the no comprehensive assessment required is if necessary plus applicable fees under tariff item No. 8.7.6 supplemental material, 8.9.7, 8.9.8





4 200







 





 





 





 







BG





4.3.1





Review a message of a biocidal product, that belongs to a biocidal product family para. 6 of the biocidal product regulation in accordance with article 17





300-





Section V

Fees applications for registration and renewal of the authorisation of a biocidal product or a biocidal product family within the framework of the Union approval in accordance with article 41 to 44 and article 45 of the biocidal product regulation, when Austria evaluating as fossilised Member State


Of the following fees are each a biocidal product or a biocidal product family to apply for, which should contain an active ingredient and allowed for a kind of product and a user category. If applicable, the additional fee referred to in section VIII shall apply.



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







VG





5.1.1





Assessment of the application for authorisation of a biocidal product within the framework of the Union approval in accordance with article 43 of the biocidal product regulation, if necessary plus fees pursuant to tariff item 8.2.1, 8.4.1, 8.4.2, 8.5.1, 8.6.1 8.6.2





7 500







BG





5.1.2





52 500







 





 





 





 







VG





5.1.3





Assessment of the application for authorisation of a biocidal product family within the framework of the Union approval in accordance with article 43 of the biocidal product regulation, if necessary plus fees pursuant to tariff item 8.2.2, 8.4.3, 8.4.4, 8.5.3, 8.6.3 and 8.6.4





15 000-







BG





5.1.4





105 000







 





 





 





 







VG





5.2.1





Assessment of the application for authorisation of a biocidal product within the framework of the Union approval in accordance with article 43 of the biocidal product regulation, which is identical to the reference product, was valued for the active substance approval





2 000-







BG





5.2.2





16 000-







 





 





 





 







VG





5.2.3





Assessment of the application for approval of a Biozidproduktfamile within the framework of the Union approval in accordance with article 43 of the biocidal product regulation, which is identical to the reference product, which has been evaluated for the active substance approval





4 500-







BG





5.2.4





31 500-







 





 





 





 







VG





5.3.1





Assessment of the application for renewal of the Union authorisation of a biocidal product in accordance with article 45 of the biocidal product regulation, of a comprehensive assessment is required, if applicable plus applicable fees under tariff item 8.3.1, 8.5.1, 8.5.2, 8.6.5





6 000-







BG





5.3.2





42 000







 





 





 





 







VG





5.3.3





Assessment of the application for renewal of the Union authorisation of a biocidal product family in accordance with article 45 of the biocidal product regulation, of a comprehensive assessment is required, if applicable plus applicable fees under tariff item 8.3.2, 8.5.3, 8.5.4, 8.6.6





12 000-







BG





5.3.4





84 000-







 





 





 





 







VG





5.3.5





Assessment of the application for renewal of the Union authorisation of a biocidal product in accordance with article 45 of the biocidal product regulation, the no comprehensive assessment is required, if necessary plus applicable fees under tariff item 8.3.3, 8.5.5, 8.5.6





1 900-







BG





5.3.6





13 100-







 





 





 





 







VG





5.3.7





Assessment of the application for renewal of the Union authorisation of a biocidal product family in accordance with article 45 of the biocidal product regulation, the no comprehensive assessment is required, if necessary plus applicable fees under tariff item 8.3.4, 8.5.7 8.5.8





3 800-







BG





5.3.8





26 200





Section VI

Fees for applications to amend an authorisation of a biocidal product or a biocidal product family in accordance with article 50 of the biocidal product regulation, if Austria as a reference Member State or fossilised Member State carries out the evaluation



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





6.1.1





Evaluation of an application to amend an authorisation of a biocidal product pursuant to article 50 of the biocidal product regulation in conjunction with article 6 of Regulation (EU) No. 354/2013, at the administrative changes in accordance with annex title 1 section 1 point 1 to 4 of Regulation (EU) No. 354/2013 are required





500-







 





 





 





 







BG





6.1.2





Evaluation of an application to amend an authorisation of a biocidal product in accordance with article 50 of the biocidal product regulation in conjunction with article 6 of Regulation (EU) No. 354/2013, at the administrative changes in accordance with annex title 1 section 1 point 5 and 6 and section 2 frt Regulation (EU) No. 354/2013 are required





800-







 





 





 





 







BG





6.1.3





Evaluation of an application to amend an authorisation of a biocidal product family in accordance with article 50 of the biocidal product regulation in conjunction with article 6 of Regulation (EU) No. 354/2013, at the administrative changes in accordance with annex title 1 section 1 point 1 to 4 of Regulation (EU) No. 354/2013 are required





500-







 





 





 





 







BG





6.1.4





Evaluation of an application to amend an authorisation of a biocidal product family in accordance with article 50 of the biocidal product regulation in conjunction with article 6 Regulation (EU) No. 354/2013, at the administrative changes in accordance with annex title 1 section 1 point 5 and 6 and section 2 of the Regulation (EU) No. 354/2013 are required





1 500-







 





 





 





 







VG





6.2.1





Evaluation of an application to amend an authorisation of a biocidal product in accordance with article 50 of the biocidal product regulation in conjunction with article 7 of the Regulation (EU) No. 354/2013, in which minor changes are required





500-







BG





6.2.2





3 000-







 





 





 





 







VG





6.2.3





Evaluation of an application to amend an authorisation of a biocidal product family in accordance with article 50 of the biocidal product regulation in conjunction with article 7 of the Regulation (EU) No. 354/2013, in which minor changes are required





1 000-







BG





6.2.4





6 000-







 





 





 





 







VG





6.3.1





Evaluation of an application to amend an authorisation of a biocidal product in accordance with article 50 of the biocidal product regulation in conjunction with article 8 of the Regulation (EU) No. 354/2013, in which substantial changes are required





2 800-







BG





6.3.2





19 700-







 





 





 





 







BG





6.3.3





Evaluation of an application to amend an authorisation of a biocidal product family in accordance with article 50 of the biocidal product regulation in conjunction with article 8 of the Regulation (EU) No. 354/2013, in which substantial changes are required





5 600







BG





6.3.4





39 400-





Section VII

Fees for applications to amend an authorisation of a biocidal product or a biocidal product family in accordance with article 50 of the biocidal product regulation, if Austria is the Member State concerned



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





7.1.1





Evaluation of an application to amend an authorisation of a biocidal product in accordance with article 50 of the biocidal product regulation in conjunction with article 6 Regulation (EU) No. 354/2013, at the administrative changes in accordance with annex title 1 section 1 point 1 to 4 of Regulation (EU) No. 354/2013 are required





400-







 





 





 





 







BG





7.1.2






Evaluation of an application to amend an authorisation of a biocidal product in accordance with article 50 of the biocidal product regulation in conjunction with article 6 Regulation (EU) No. 354/2013, at the administrative changes in accordance with annex title 1 section 1 point 5 and 6 and section 2 of the Regulation (EU) No. 354/2013 are required





700-







 





 





 





 







BG





7.1.3





Evaluation of an application to amend an authorisation of a biocidal product family in accordance with article 50 of the biocidal product regulation in conjunction with article 6 of Regulation (EU) No. 354/2013, at the administrative changes in accordance with annex, title 1 section 1 point 1 – 4 Regulation (EU) No. 354/2013 are required





500-







 





 





 





 







BG





7.1.4





Evaluation of an application to amend an authorisation of a biocidal product family in accordance with article 50 of the biocidal product regulation in conjunction with article 6 Regulation (EU) No. 354/2013, at the administrative changes in accordance with annex title 1 section 1 point 5 and 6 and section 2 of the Regulation (EU) No. 354/2013 are required





1 300-







 





 





 





 







BG





7.2.1





Evaluation of an application to amend an authorisation of a biocidal product in accordance with article 50 of the biocidal product regulation in conjunction with article 7 of the Regulation (EU) No. 354/2013, in which minor changes are required





500-







 





 





 





 







BG





7.2.2





Evaluation of an application to amend an authorisation of a biocidal product family in accordance with article 50 of the biocidal product regulation in conjunction with article 7 of the Regulation (EU) No. 354/2013, in which minor changes are required





1 000-







 





 





 





 







BG





7.3.1





Evaluation of an application to amend an authorisation of a biocidal product in accordance with article 50 of the biocidal product regulation in conjunction with article 8 of the Regulation (EU) No. 354/2013, in which substantial changes are required





3 500-







 





 





 





 







BG





7.3.2





Evaluation of an application to amend an authorisation of a biocidal product family in accordance with article 50 of the biocidal product regulation in conjunction with article 8 of the Regulation (EU) No. 354/2013, in which substantial changes are required





7 000-





Section VIII

Additional fees

If the below fees to the fees referred to in sections I, II, are true to add IV, and V.

1. fees for applications for the provisional authorisation of a biocidal product or a family of biocidal products in accordance with article 55 para 2 of the biocidal product regulation

Of the following fees are in the case that it is the proposed biocidal product or the requested biocidal product family to the reference product, to add the fee to the assessment of the active substance (section I) for the Austria evaluating.



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





8.1.1





Assessment of the application for provisional registration of a biocidal product in accordance with article 55 para 2 of the biocidal product regulation

In addition to tariff post 1.1.2, 1.1.5





5 000-







 





 





 





 







BG





8.1.2





Assessment of the application for provisional registration of a biocidal product in accordance with article 55 para 2 of the biocidal product regulation: each other already approved active substance in the biocidal product

In addition to tariff post 1.1.2, 1.1.5





1 000-







 





 





 





 







BG





8.1.3





Assessment of the application for provisional registration of a biocidal product family in accordance with article 55 para 2 of the biocidal product regulation

In addition to tariff post 1.1.2, 1.1.5





10 000-







 





 





 





 







BG





8.1.4





Assessment of the application for provisional registration of a biocidal product family in accordance with article 55 para 2 of the biocidal product regulation: each other already approved active substance in the biocidal product

In addition to tariff post 1.1.2, 1.1.5





2 000-







 





 





 





 







BG





8.1.5





Assessment of the application for provisional registration of a biocidal product in accordance with article 55 para 2 of the biocidal product regulation, if the biocidal product is identical to the reference product, that for the active substance approval was rated

In addition to tariff post 1.1.2, 1.1.5





2 000-







 





 





 





 







BG





8.1.6





Assessment of the application for provisional registration of a biocidal product family in accordance with article 55 para 2 of the biocidal product regulation, if the biocidal product is identical to the reference product, that for the active substance approval was rated

In addition to tariff post 1.1.2, 1.1.5





4 000-





2. additional fees for applications for national approval and renewal of the national authorisation and Union approval and renewal of the Union authorisation of a biocidal product or a biocidal product family, when Austria as a reference Member State or fossilised Member State carries out the evaluation

2.1 additional fees for applications for registration and renewal of the authorisation of a biocidal product or a biocidal product family in procedures referred to in articles 17 and 29, article 31 and article 34 para 1 of the biocidal product regulation, if contain more than an active ingredient is one or more substances of concern (in accordance with article 3 par. 1 lit. f of the biocidal product regulation) is been contained, affected more than one product type and/or more than one user category applied for.



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





8.2.1





In the context of the review of an application for authorisation of a biocidal product



-each additional active ingredient contained in the biocidal product - based on another product type - depending on another user category - each included substance in addition to tariff item 2.1.2, 5.1.2





5 000-







 





 





 





 







BG





8.2.2





In the context of the review of an application for authorisation of a biocidal product family



-each additional active ingredient contained in the biocidal product - based on another product type - depending on another user category - each included substance in addition to tariff item 2.1.4, 5.1.4





10 000-







 





 





 





 







BG





8.3.1





In the context of the review of an application for renewal of the authorisation of a biocidal product, is required for a comprehensive evaluating



-each additional active ingredient contained in the biocidal product - based on another product type - depending on another user category - each included substance in addition to tariff item 2.3.2, 5.3.2





4 000-







 





 





 





 







BG





8.3.2





In the context of the review of an application for renewal of the authorisation of a biocidal product family, is required for a comprehensive evaluating



-each additional active ingredient contained in the biocidal product - based on another product type - depending on another user category - each included substance in addition to tariff item 2.3.4, 5.3.4





8 000







 





 





 





 







BG





8.3.3





In the context of the review of an application for renewal of the authorisation of a biocidal product where no comprehensive assessment is required



-each additional active ingredient contained in the biocidal product - based on another product type - depending on another user category - each included substance in addition to tariff item 2.3.6, 5.3.6





1 250







 





 





 





 







BG





8.3.4





In the context of the review of an application for renewal of the authorisation of a biocidal product family, where no comprehensive assessment is required



-each additional active ingredient contained in the biocidal product


-each additional product type - ever another user category - each included substance in addition to tariff item 2.3.8, 5.3.8





2 500-





2.2 additional fees for applications for registration and renewal of the authorisation of a biocidal product or a biocidal product family in procedures referred to in articles 17 and 29, article 31 and article are 34 para 1 of the biocidal product regulation, when to replace substances in accordance with article 10 of the biocidal product regulation in these biocidal products contain.



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





8.4.1





In the context of the review of an application for authorisation of a biocidal product



-Comparative assessment pursuant to article 23 of the biocidal product regulation for a contained, to replace active ingredient



23 800-







BG





8.4.2







- and ever further contained, to replace active ingredient in addition to tariff item 2.1.2, 5.1.2



11 900-







 





 





 





 







BG





8.4.3





In the context of the review of an application for authorisation of a biocidal product family



-Comparative assessment pursuant to article 23 of the biocidal product regulation for a contained, to replace active ingredient



45 000







BG





8.4.4







- and ever further contained, to replace active ingredient in addition to tariff item 2.1.4, 5.1.4



22 500







 





 





 





 







BG





8.5.1





In the context of the review of an application for renewal of the authorisation of a biocidal product



-Comparative assessment pursuant to article 23 of the biocidal product regulation for a contained, to replace active ingredient



19 000-







BG





8.5.2







- and ever further contained, to replace active ingredient in addition to tariff items, 2.3.2, 5.3.2



9 500







 





 





 





 







BG





8.5.3





In the context of the review of an application for renewal of the authorisation of a biocidal product family



-Comparative assessment pursuant to article 23 of the biocidal product regulation for a contained, to replace active ingredient



38 000







BG





8.5.4







- and ever further contained, to replace active ingredient in addition to tariff item 2.3.4, 5.3.4



19 000-







 





 





 





 







BG





8.5.5





In the context of the review of an application for renewal of the authorisation of a biocidal product where no comprehensive assessment is required



-Comparative assessment pursuant to article 23 of the biocidal product regulation for a contained, to replace active ingredient



6 200







BG





8.5.6







- and ever further contained, to replace active ingredient in addition to tariff item 2.3.6, 5.3.6



3 100







 





 





 





 







BG





8.5.7





In the context of the review of an application for renewal of authorisation of a biocidal product family, where no comprehensive assessment is required



-Comparative assessment pursuant to article 23 of the biocidal product regulation for a contained, to replace active ingredient



12 400-







BG





8.5.8







- and ever further contained, to replace active ingredient in addition to tariff item 2.3.8, 5.3.8



6 200





2.3 additional fees for applications for registration and renewal of the authorisation of a biocidal product or a biocidal product family in procedures referred to in articles 17 and 29, article 31 and article 34 para 1 of the biocidal product regulation, when setting maximum residue limits (MRLs) is required.



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





8.6.1





Assessment of an application for the establishment of maximum residue limits in accordance with article 19 para 7 of the biocidal product regulation for a biocidal product, if it not already in accordance with the article 19 paragraph 1 lit. e of the biocidal product regulation laid down legal regulations stated and are applicable

In addition to tariff item 2.1.2, 5.1.2





7 500







 





 





 





 







BG





8.6.2





Assessment of an application for the establishment of maximum residue limits in accordance with article 19 para 7 of the biocidal product regulation for a biocidal product, if this already according to the article 19 paragraph 1 lit. e of the biocidal product regulation laid down legal regulations stated and are applicable

In addition to tariff item 2.1.2, 5.1.2





1 000-







 





 





 





 







BG





8.6.3





Assessment of an application for the establishment of maximum residue limits in accordance with article 19 para 7 of the biocidal product regulation for a biocidal product family, if it not already in accordance with the article 19 paragraph 1 lit. e of the biocidal product er order legislation referred to have been set and are applicable

In addition to tariff item 2.1.4, 5.1.4





12 000-







 





 





 





 







BG





8.6.4





Assessment of an application for the establishment of maximum residue limits in accordance with article 19 para 7 of the biocidal product regulation for a biocidal product family, if this already according to the article 19 paragraph 1 lit. e of the biocidal product regulation laid down legal regulations stated and are applicable

In addition to tariff item 2.1.4, 5.1.4





1 500-







 





 





 





 







BG





8.6.5





Assessment of the application for renewal of authorisation of a biocidal product - new or changed setting maximum residue limits in accordance with article 19 para 7 of the biocidal product regulation, if it not already in accordance with the article 19 paragraph 1 lit. e of the biocidal product regulation laid down legal regulations stated and are applicable

In addition to tariff item 2.3.2, 5.3.2





5 000-







 





 





 





 







BG





8.6.6





Assessment of the application for renewal of authorisation of a biocidal product family - new or changed setting maximum residue limits in accordance with article 19 para 7 of the biocidal product regulation, if it not already in accordance with the article 19 paragraph 1 lit. e of the biocidal product regulation laid down legal regulations stated and are applicable

In addition to tariff item 2.3.4, 5.3.4





10 000-





3. additional fees for applications for registration and renewal of the authorisation of a biocidal product or a biocidal product family, if Austria is the Member State concerned

3.1 additional fees for applications for registration and renewal of the authorisation of a biocidal product or a biocidal product family in accordance with articles 31, 33 and 34 para. 2 of the biocidal product regulation, if contain more than an active ingredient is one or more substances of concern (pursuant to article 3 par. 1 lit. f of the biocidal product regulation) are included, more than one product type affected or more than one user category has been applied for.



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





8.7.1





In the context of the review of an application for authorisation of a biocidal product



-ever further active ingredient contained in the biocidal product - based on another type of product - based on another user category - each included substance in addition to tariff item 4.1.1



650-







 





 





 





 







BG





8.7.2





In the context of the review of an application for authorisation of a biocidal product family



-ever further active ingredient contained in the biocidal product - based on another type of product - based on another user category - each included substance in addition to tariff item 4.1.2



1 300-







 





 





 





 







BG





8.7.3





In the context of the review of an application for renewal of an authorisation of a biocidal product; comprehensive assessment



-ever further active ingredient contained in the biocidal product - based on another type of product - based on another user category - each included substance


In addition to tariff item 4.2.1



500-







 





 





 





 







BG





8.7.4





In the context of the review of an application for renewal of authorisation of a biocidal product family. comprehensive assessment



-ever further active ingredient contained in the biocidal product - based on another type of product - based on another user category - each included substance in addition to tariff item 4.2.2





1 000-







 





 





 





 







BG





8.7.5





In the context of the review of an application for renewal of an authorisation of a biocidal product; no comprehensive assessment



-ever further active ingredient contained in the biocidal product - based on another type of product - based on another user category - each included substance in addition to tariff item 4.2.3



200-







 





 





 





 







BG





8.7.6





In the context of the review of an application for renewal of authorisation of a biocidal product family. no comprehensive assessment



-ever further active ingredient contained in the biocidal product - based on another type of product - based on another user category - each included substance in addition to tariff item 4.2.4





400-





3.2 additional fees for applications for registration and renewal of the authorisation of a biocidal product or a biocidal product family in accordance with articles 31, 33 and 34 are para. 2 of the biocidal product regulation, when to replace substances in accordance with article 10 of the biocidal product regulation in these biocidal products contain.



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





8.8.1





In the context of the review of an application for authorisation of a biocidal product



-comparative assessment pursuant to article 23 of the biocidal product regulation for a contained, to replace active ingredient



4 200







BG





8.8.2







- and ever further contained, to replace active ingredient in addition to rate post 4.1.1



2 100-







 





 





 





 







BG





8.8.3





In the context of the review of an application for authorisation of a biocidal product family



-comparative assessment pursuant to article 23 of the biocidal product regulation for a contained, to replace active ingredient



8 500







BG





8.8.4







- and ever further contained, to replace active ingredient in addition to rate post 4.1.2



4 200







 





 





 





 







BG





8.9.1





In the context of the review of an application for renewal of an authorisation of a biocidal product, is required for a comprehensive evaluating



-comparative assessment pursuant to article 23 of the biocides regulation for a contained, to replace active ingredient



3 300







BG





8.9.2







- and ever further contained, to replace active ingredient in addition to rate post 4.2.1



1 600-







 





 





 





 







BG





8.9.3





In the context of the review of an application for renewal of authorisation of a biocidal product family, is required for a comprehensive evaluating



-comparative assessment pursuant to article 23 of the biocidal product regulation for a contained, to replace active ingredient



6 600







BG





8.9.4







- and ever further contained, to replace active ingredient in addition to rate post 4.2.2



3 300







 





 





 





 







BG





8.9.5





In the context of the review of an application for renewal of authorisation of a biocidal product, where no comprehensive assessment is required



-comparative assessment pursuant to article 23 of the biocidal product regulation for a contained, to replace active ingredient



1 100-







BG





8.9.6







- and ever further contained, to replace active ingredient in addition to rate post 4.2.3



500-







 





 





 





 







BG





8.9.7





In the context of the review of an application for renewal of authorisation of a biocidal product family, where no comprehensive assessment is required



-comparative assessment pursuant to article 23 of the biocidal product regulation for a contained, to replace active ingredient



2 200







BG





8.9.8







- and ever further contained, to replace active ingredient in addition to rate post 4.2.4



1 000-





3.3 additional fees for applications for authorisation of a biocidal product or a biocidal product family in accordance with articles 31, 33 and 34 para. 2 of the biocidal product regulation, when setting maximum residue limits (MRLs) is required.



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





8.10.1





Assessment of an application for the establishment of maximum residue limits in accordance with article 19 para 7 of the biocidal product regulation for a biocidal product, if it not already in accordance with the article 19 paragraph 1 lit. e of the biocidal product regulation laid down legal regulations stated and are applicable

In addition to tariff post 4.1.1





1 200-







 





 





 





 







BG





8.10.2





Assessment of an application for the establishment of maximum residue limits in accordance with article 19 para 7 of the biocidal product regulation for a biocidal product, if this already according to the article 19 paragraph 1 lit. e of the biocidal product regulation laid down legal regulations stated and are applicable

In addition to tariff post 4.1.1





150-







 





 





 





 







BG





8.10.3





Assessment of an application for the establishment of maximum residue limits in accordance with article 19 para 7 of the biocidal product regulation for a biocidal product family, if it not already in accordance with the article 19 paragraph 1 lit. e of the biocidal product regulation laid down legal regulations stated and are applicable

In addition to tariff post 4.1.2





1 800-







 





 





 





 







BG





8.10.4





Assessment of an application for the establishment of maximum residue limits in accordance with article 19 para 7 of the biocidal product regulation for a biocidal product family, if this already according to the article 19 paragraph 1 lit. e of the biocidal product regulation laid down legal regulations stated and are applicable

In addition to tariff post 4.1.2





220-





4. other fees



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





8.11.1





Assessment of the application for authorisation of a biocidal product or a biocidal product family by Austria as a reference Member State when an alternative dossier is presented for a contained substance which has not yet been rated by another Member State

In addition to tariff item 2.1.2, 2.1.4





125 000





Section IX

Other fees for an application or notification procedure in accordance with article 53 paragraph 1, article 55 para 1 of subpara. 1, art. 56 para. 2 and art. 66 par. 4 of the biocidal product regulation



Fees-art





Collective post





Procedures / regulatory activities





Fee in euro







BG





9.1.1





Approval for parallel trade of a biocidal product in accordance with article 53 paragraph 1 of the biocidal product regulation





2 000-







 





 





 





 







BG





9.1.2





Renewal of the authorisation for parallel trade of a biocidal product in accordance with article 53 paragraph 1 of the biocidal products directive





1 600-







 





 





 





 







BG





9.1.3





Assessment of the application for authorisation an exception pursuant to article 55 para 1 of subpara. 1 of the biocidal product regulation





12 000,-4)







 





 





 





 







BG






9.1.4





Message an experiment or trial in accordance with article 56 para 2 of the biocidal product regulation





1 000-







 





 





 





 







BG





9.1.5





Assessment of the application for confidential treatment of data according to article 66 para 4 of the biocidal product regulation, each detail information, not by article 66 par. 2 is covered





100-





Section X

Annual fees



Fees-art





Collective post





Biocidal product / biocidal product family





Fee in euro







JG





10.1.1





Annual fee for an authorised biocidal product per calendar year





500-







 





 





 





 







JG





10.1.2





Annual fee for an authorised biocidal product family per calendar year





1 000-





4) para 1 of subpara can an application for authorisation of a biocidal product in danger in delay in accordance with article 55. 1 of the biocidal product regulation be denied only if the procedure is also an assessment of the active substance in accordance with article 7 and 8 of the biocidal product regulation, shall be borne AVG arising from the evaluation of the active ingredient of cash outlays of the authority by the applicant in accordance with the section 76.